CMV pneumonitis overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMV Pneumonitis}}
{{CMV pneumonitis}}
{{CMG}}
{{CMG}}



Latest revision as of 18:26, 25 September 2012

CMV pneumonitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating CMV pneumonitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

CMV pneumonitis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of CMV pneumonitis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on CMV pneumonitis overview

CDC on CMV pneumonitis overview

CMV pneumonitis overview in the news

Blogs on CMV pneumonitis overview

Directions to Hospitals Treating CMV pneumonitis

Risk calculators and risk factors for CMV pneumonitis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cytomegalovirus (CMV) is a major cause of morbidity and mortality in immunocompromised hosts, and pneumonitis is a common manifestation of CMV infection. When immunocompromised patients present with fever and dyspnea, CMV pneumonitis should be a consideration.

References

Template:WH Template:WS